http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109675065-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9de52bba13e16028dffa8775e3f3f28
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1854
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
filingDate 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7991c8b711468c1d957ecfa58d33536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dabdcc101e068cb65c9205eeed9df13
publicationDate 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109675065-A
titleOfInvention Nanomagnetic beads for T1 and T2 magnetic resonance dual-modality imaging and preparation method thereof
abstract The invention relates to a nano-magnetic bead for T1 and T2 magnetic resonance dual-mode imaging and a preparation method thereof. The nano-magnetic bead comprises a nano-ferric oxide magnetic bead and a polymeric nano-bead wrapped on the outside of the nano-ferric oxide magnetic bead. Acrylic acid shell, when preparing, dissolving ferric salt and divalent ferrous salt in concentrated hydrochloric acid to obtain a salt solution, adding the salt solution to the polyacrylic acid aqueous solution, after mixing evenly, heating and refluxing under N2 environment, Then add concentrated ammonia water, and after the reaction is completed, cool, filter and purify to obtain the product. Compared with the prior art, the present invention provides a preparation method of ultra-small nano-magnetic beads for T1 and T2 magnetic resonance dual-modal imaging, which has simple process, mild reaction conditions, low cost, no pollution, and The contrast agent can be metabolized in vivo and can be used as a clinical magnetic resonance contrast agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112133553-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112133553-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021190573-A1
priorityDate 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101649101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104758956-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447773061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450540594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452805844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364

Total number of triples: 37.